Position in ZTS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$420,505,812
-$233,435,211 QoQ
Shares Held
5,851,737
+5.8% QoQ
Ownership
1.42%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#10
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Mar 31, 2020CallValue
$5,178
CallShares
44
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $1,001,919,079 across 44 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (42.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
5,851,737 | $420,505,812 | |
| 2 | VTRS |
Viatris Inc
|
7,891,271 | $125,313,379 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
195,269 | $105,802,598 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,037,225 | $102,901,179 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
334,650 | $56,401,907 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
248,743 | $27,595,547 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
323,443 | $26,774,610 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
387,606 | $24,787,402 |
All Filings in ZTS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $420,505,812 | 5,851,737 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $653,941,023 | 5,532,028 | Shares | Other | 2026-05-06 | |
| 2025-12-31 | $699,330,578 | 5,558,183 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $682,767,448 | 4,666,262 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $599,196,071 | 3,842,232 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $496,855,899 | 3,017,649 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $470,700,525 | 2,888,974 | Shares | Sole | 2025-06-30 | |
| 2024-09-30 | $435,245,479 | 2,227,687 | Shares | Sole | 2025-06-26 | |
| 2024-06-30 | $350,321,546 | 2,020,775 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $308,004,664 | 1,820,251 | Shares | Sole | 2025-06-02 | |
| 2023-12-31 | $389,164,882 | 1,971,753 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $294,604,851 | 1,693,326 | Shares | Sole | 2023-11-24 | |
| 2023-06-30 | $315,507,656 | 1,832,110 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $292,808,232 | 1,759,242 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $261,288,092 | 1,782,928 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $287,563,366 | 1,939,196 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $345,163,362 | 2,008,048 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $394,153,093 | 2,090,000 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $415,431,782 | 1,702,380 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $446,417,934 | 2,299,464 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $324,701,542 | 1,742,335 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $259,918,053 | 1,650,483 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $256,801,051 | 1,551,668 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $282,386,796 | 1,707,606 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $212,718,962 | 1,552,240 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $231,266,608 | 1,965,049 | Shares | Defined | 2020-05-14 | |
| 2020-03-31 | $5,178 | 44 | Call | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||